194 related articles for article (PubMed ID: 23750225)
1. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
[TBL] [Abstract][Full Text] [Related]
2. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
[TBL] [Abstract][Full Text] [Related]
3. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.
Shang P; Xia Y; Liu F; Wang X; Yuan Y; Hu D; Tu D; Chen Y; Deng P; Cheng S; Zhou L; Ma Y; Zhu L; Gao W; Wang H; Chen D; Yang L; He P; Wu S; Tang S; Lv X; Shu Z; Zhang Y; Yang Z; Chen Y; Li N; Sun F; Li X; He Y; Garner P; Zhan S
PLoS One; 2011; 6(7):e21836. PubMed ID: 21750735
[TBL] [Abstract][Full Text] [Related]
4. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
[TBL] [Abstract][Full Text] [Related]
5. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis.
Laghari M; Talpur BA; Syed Sulaiman SA; Khan AH; Bhatti Z
Int J Mycobacteriol; 2020; 9(3):281-288. PubMed ID: 32862161
[TBL] [Abstract][Full Text] [Related]
7. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
Yang M; Pan H; Lu L; He X; Chen H; Tao B; Liu W; Yi H; Tang S
BMJ Open; 2019 Mar; 9(3):e027321. PubMed ID: 30928962
[TBL] [Abstract][Full Text] [Related]
8. Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India: A Prospective Study.
Siddiqui AN; Khayyam KU; Sharma M
Biomed Res Int; 2016; 2016():7273935. PubMed ID: 27642601
[TBL] [Abstract][Full Text] [Related]
9. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
[TBL] [Abstract][Full Text] [Related]
10. Adverse Drug Reaction Patterns of First-line Anti-tubercular Drugs among Saharia Tuberculosis Patients: An Observational Study in Particularly Vulnerable Tribal Group of Madhya Pradesh, India.
Mishra P; Bhat J; Yadav R; Sharma RK; Rao VG
Indian J Public Health; 2023 Oct; 67(4):542-545. PubMed ID: 38934815
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis in Asia].
Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases.
Jones J; Mudaly V; Voget J; Naledi T; Maartens G; Cohen K
BMC Infect Dis; 2019 Jun; 19(1):544. PubMed ID: 31221100
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
[TBL] [Abstract][Full Text] [Related]
14. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
[TBL] [Abstract][Full Text] [Related]
15. Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China.
Zhao Z; Peng W; Wu L; Ying B
J Infect Chemother; 2020 Jan; 26(1):63-68. PubMed ID: 31405785
[TBL] [Abstract][Full Text] [Related]
16. Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients.
Ahmad N; Javaid A; Syed Sulaiman SA; Afridi AK; Zainab ; Khan AH
Am J Ther; 2018; 25(5):e533-e540. PubMed ID: 26938643
[TBL] [Abstract][Full Text] [Related]
17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
18. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
P V K; Palaian S; Ojha P; P R S
Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study.
Dela AI; Tank NKD; Singh AP; Piparva KG
Lung India; 2017; 34(6):522-526. PubMed ID: 29098997
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation.
Salvador NGA; Wee SY; Lin CC; Wu CC; Lu HI; Lin TL; Lee WF; Chan YC; Lin LM; Chen CL
Ann Transplant; 2018 Oct; 23():733-743. PubMed ID: 30337516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
